Insider Title Company Date Price Return Shares Value
Adams Helen C. Non-Executive Director Immix Biopharma, Inc. (IMMX) 2023-09-12 $2.96 -29.1% 13,000 $38,492
Adams Helen C. Non-Executive Director Prometheus Biosciences, Inc. (RXDX) 2021-03-16 $19.00 952.2% 500 $9,500
Return Profit / (loss) Cost
Total 165.2% $79,268 $47,992